KRAS and metastatic neoplasm: The metastatic tumors retained most of the genetic variants found in the original tumors, but some cases had additional CNVs, including copy number gains for the KRAS, AKT3, RICTOR, FGFR, and FANCD2 genes, and copy number losses for the MYC and RAD50 genes.